Merck & Co (MRK)
$125.85
1.87 (1.46%)
MRK Stock Quote Delayed 30 Minutes
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
318.57B
PE Ratio
139.83
EPS
0.9
Volume (Avg. Vol.)
4.00M
Day's Range
$125.30 - $127.94
52-Week Range
$99.14 - $134.63
Dividend & Yield
$2.92 (2.32%)
MRK Stock Predictions, Articles, and Merck & Co News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.
Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.
Why Is Moderna (MRNA) Stock Up 11% Today?
Moderna stock is on the rise Thursday as investors in MRNA react to positive results from a skin cancer vaccine in a Phase 2b trial.
Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?
C4 Therapeutics stock is rising higher on Tuesday as investors in CCCC shares celebrate a new collaboration agreement with Merck.
Worried About a Recession? This Pharma Stock Could Be the Safe Haven You Need.
Merck has a slew of in-progress products in its pipeline and pays a decent dividend. So, consider shoring up your portfolio with MRK stock.
Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare
Healthcare stocks are starting to shine in 2023 after bottoming out and MRK stock is particularly appealing. Here's why.
